Oculis Holding AG - Ordinary shares (OCS)

Oculis (OCS) beat Q3 2025 earnings estimates, extended cash runway into 2029, and advanced its late-stage ophthalmology pipeline with key clinical milestones ahead.

OCS stock results show that Oculis Holding missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

U.S. stock futures were slightly higher this morning, with the Dow Jones futures gaining around 15 points on Thursday. Shares of FLJ Group Limited(NASDAQ: FLJ) rose sharply in pre-market trading.

U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. SunCar Technology Group Inc. (NASDAQ: SDA) shares gained 51.5% to $29.53.

Gainers